All Long-term conditions articles – Page 13
-
SupplementsHow to spot a good app
Tricky but essential - the job of evaluating the many health apps on the market
-
NewsJudge rules minimally conscious patient should be allowed to die
Court ruling declared as a landmark decision that could affect future cases Patient will die after life sustaining treatment is withdrawn Judge says continuing care would be “disrespectful” to her wishes A woman in the end stage of multiple sclerosis will be allowed to die after a landmark ...
-
NewsExclusive: NHS England finds 'unfair inequalities' in orthotics access
Review finds ’unfair’ variation, including waiting times longer than a year Follows concerns raised by Healthwatch An NHS England review has found “avoidable and unfair inequalities” in access to splints, braces and other orthoses.
-
-
-
SupplementsSupplement: It's time to heal wound management
Rising numbers call for better management
-
CommentThe NHS must employ more people with disabilities
How disabilities impact on the NHS workforce
-
-
Supplements
Value in Healthcare Awards: Value and Improvement in Medicines Management
Value in Healthcare Awards winners for 2015
-
Supplements
Value in Healthcare Awards: Value and Improvement in using IT to support integrated healthcare services
Value in Healthcare Awards winners for 2015
-
-
NewsMonitor: Out of hospital care ‘no panacea’ for demand pressure
Monitor has warned providers that schemes to move care out of hospital are not guaranteed to reduce costs or demand pressure.
-
HSJ KnowledgeSeven day services: Setting up shop on the high street
What GPs can learn from vet practices
-
HSJ KnowledgeDiabetes and diet: There's an epidemic of misinformation
Doctors and patients have misguided perceptions
-
-
-
-
-
NewsReview to consider ‘cancer drugs fund’ for innovative medicines
The government’s accelerated access review will look at whether the principle of the cancer drugs fund could be extended to non-cancer treatments, its chair has said.
-
NewsExclusive: DH funds private prescriptions for drug denied to NHS patients
Taxpayers’ money is being used by the Department of Health to pay for private prescriptions for a £12,000 a year drug to treat narcolepsy, HSJ has learned.